Biotechnology company focused on the development of a therapeutic HIV vaccine to be used as part of a cure/eradication strategy.
For 30 years, we have worked for leading edge companies and organizations involved in a wide range of emerging technologies
Group composed of privately-held biopharmaceutical companies specialised in the development of innovative therapeutics for the treatment of metabolic diseases and cancer.
Alizé Pharma 3 develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Its ambition is to become a leading company in rare diseases with operations in the US and Europe, geared to supporting the global development of products.
Pioneering a curative approach to treat autoimmune diseases, in particular Crohn’s disease and rheumatoid arthritis.
BCI Pharma is a biotech company with extensive expertise in medicinal chemistry, with a special focus on an innovative chemical library. The company designs and validates innovative kinase inhibitors libraries (Bikin 1-3).
Biotechnology company providing best-in-class cell internalization technologies for novel drug designs and developments
City complex for healthcare and biotechnology companies. Biocitech fosters business innovation and provides a complete range of services to residents from inception through to business maturity.
Biomunex is a biopharmaceutical company focused on providing immuno-therapeutics through the discovery and development of bi- and multi-specific antibodies, created from its next generation proprietary BiXAb® platform
Bionure is a biotechnology company, a spin-off from the Hospital Clinic of Barcelona (Spain), developing the neuroprotectant BN201
Aims to develop gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain.
CardioRenal is a company dedicated to improving the quality of treatment for heart failure patients through the use of state-of-the art technology (expert systems, real-time diagnosis, microfluidics, etc.) combined with top medical expertise.
With nine facilities located in France (Evreux and Saint-Nazaire), Canada (Laval and Boisbriand), US (Kansas-City), Denmark (Copenhagen) and Hungary (Veszprem, Budapest, Szeged), Citoxlab Group offers a comprehensive range of preclinical services to meet the needs of pharmaceutical, biotechnology, medical device, chemical and agrochemical companies worldwide.
Discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs).
GamaMabs Pharma is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer.
Clinical-stage biotechnology company, focused on the discovery and development of novel small molecule anti-cancer therapeutics
Genoskin is a spin-off of the French National Center for Scientific Research (CNRS) and the Paul Sabatier University. The company provides unique human skin models to test chemical, pharmaceutical and cosmetic products in order to avoid animal experiments.
iDD biotech is a biopharmaceutical company discovering and developing innovative drugs based on antibodies with potential in the treatment of cancer and autoimmune diseases.
Develops active targeted immunotherapies to treat and prevent severe chronic diseases caused by disruptions of the immune system.
Contract Research Biotech (CRB) that aims to innovate and develop new technologies for the benefit of its pharmaceutical and biotechnology industry clients, supporting them in developing safer pharmacological agents.
Founded in 2007, Minasolve is a supplier of premium and innovative solutions for cosmetic applications based on green and sustainable production processes.
Minoryx is a drug development company specializing in the discovery and development of new drugs for orphan diseases. The company targets Inborn Errors of Metabolism, a group of rare diseases of genetic origin with a high unmet medical need.
Mutabilis is specialized in the discovery of new therapeutic approaches for treating bacterial infections (spin-off from INSERM)
Biotechnology company specialized in the research and development of new antibacterial molecules.
Créée il y a plus de 20 ans par le Dr. Philippe Genne, PDG et actionnaire principal, Oncodesign est une entreprise biopharmaceutique spécialisée en médecine de précision.
Spin-off of the French Blood Bank (EFS), the company develops a new class of potent and scalable therapeutic universal antigen presenting cell, based on a proprietary cell line of Plasmacytoid Dendritic cells (PDC*line).
Biopharmaceutical company, dedicated to the discovery and development of transmembrane therapeutic peptides.
Pherecydes Pharma SA specializes in research into innovative and adaptive solutions to fight multi-resistant bacterial infections, using cocktails of natural phages.
Develops innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders.
SparingVision is a biotechnology company focused on the discovery and development of an innovative, therapeutic approach for treatment of inherited retinal diseases such as retinitis pigmentosa.
Univercells leverages manufacturing sciences to design single-use bioprocess solutions that change the rules in biomanufacturing. Univercells aims to make biologics available and affordable for all by re-inventing the way they are manufactured across the globe. The company creates value for manufacturers and healthcare systems with cost efficiency and local supply while increasing patients’ access to healthcare.
Biopharmaceutical company developing therapeutic cancer vaccines based on optimized cryptic peptides.
Biotechnology company offering innovative and effective solutions for the cryopreservation of even the most sensitive cells.
Yposkesi is the largest European Contract Development & Manufacturing Organization (CDMO) for gene therapy vector manufacturing. Created in November 2016 in Corbeil- Essonnes (France) as a spin off from the world-class gene therapy pioneer Genethon
Ypso-Facto is a service company created in 2014, with the objective to help industrial firms develop, secure and optimize their chemical and bio-processes.